These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25257790)

  • 1. Aplysin sensitizes cancer cells to TRAIL by suppressing P38 MAPK/survivin pathway.
    Liu J; Ma L; Wu N; Liu G; Zheng L; Lin X
    Mar Drugs; 2014 Sep; 12(9):5072-88. PubMed ID: 25257790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation.
    Pennati M; Sbarra S; De Cesare M; Lopergolo A; Locatelli SL; Campi E; Daidone MG; Carlo-Stella C; Gianni AM; Zaffaroni N
    Int J Cancer; 2015 Jan; 136(2):299-309. PubMed ID: 24866585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level.
    Gong A; Ge N; Yao W; Lu L; Liang H
    Cancer Chemother Pharmacol; 2014 Sep; 74(3):531-8. PubMed ID: 25047724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.
    Stolfi C; Caruso R; Franzè E; Rizzo A; Rotondi A; Monteleone I; Fantini MC; Pallone F; Monteleone G
    Mol Cancer Ther; 2011 Oct; 10(10):1969-81. PubMed ID: 21817114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose 5-fluorouracil sensitizes HepG2 cells to TRAIL through TRAIL receptor DR5 and survivin-dependent mechanisms.
    Yang L; Wang Y; Zheng H; Zhang D; Wu X; Sun G; Yang T
    J Chemother; 2017 Jun; 29(3):179-188. PubMed ID: 28067150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-494 Sensitizes Gastric Cancer Cells to TRAIL Treatment Through Downregulation of Survivin.
    Xu S; Li D; Li T; Qiao L; Li K; Guo L; Liu Y
    Cell Physiol Biochem; 2018; 51(5):2212-2223. PubMed ID: 30537730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyl jasmonate down-regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL-induced cytotoxicity.
    Raviv Z; Zilberberg A; Cohen S; Reischer-Pelech D; Horrix C; Berger MR; Rosin-Arbesfeld R; Flescher E
    Br J Pharmacol; 2011 Nov; 164(5):1433-44. PubMed ID: 21486277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiourea compound AW00178 sensitizes human H1299 lung carcinoma cells to TRAIL-mediated apoptosis.
    Ryu BJ; Hwang MK; Park M; Lee K; Kim SH
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3862-5. PubMed ID: 22622069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivo.
    Mao HL; Pang Y; Zhang X; Yang F; Zheng J; Wang Y; Liu P
    Oncol Rep; 2013 Feb; 29(2):515-22. PubMed ID: 23151974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation.
    Kim JY; Kim EH; Kim SU; Kwon TK; Choi KS
    Carcinogenesis; 2010 Mar; 31(3):367-75. PubMed ID: 19939880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway.
    Kim YH; Lee DH; Jeong JH; Guo ZS; Lee YJ
    Biochem Pharmacol; 2008 May; 75(10):1946-58. PubMed ID: 18377872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.
    Yan S; Qu X; Xu C; Zhu Z; Zhang L; Xu L; Song N; Teng Y; Liu Y
    J Cancer Res Clin Oncol; 2012 Aug; 138(8):1279-89. PubMed ID: 22447040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.
    Sung B; Ravindran J; Prasad S; Pandey MK; Aggarwal BB
    J Biol Chem; 2010 Nov; 285(46):35418-27. PubMed ID: 20837473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aplysin induces apoptosis in glioma cells through HSP90/AKT pathway.
    Gong AJ; Gong LL; Yao WC; Ge N; Lu LX; Liang H
    Exp Biol Med (Maywood); 2015 May; 240(5):639-44. PubMed ID: 25377176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF; Chen HL; Liu CY; Tai WT; Ichikawa K; Chen PJ; Cheng AL
    Biochem Pharmacol; 2012 Mar; 83(6):769-77. PubMed ID: 22230479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p-Hydroxylcinnamaldehyde from cochinchinamomordica seed reverses resistance to TRAIL in human oesophageal squamous cell carcinoma via the activation of the p38 mitogen-activated protein kinase signalling pathway.
    Ma M; Zhang C; Xiang XH; Deng XQ; Dai SL; Wei SS; Zhang XM; Zhao LM; Liu YJ; Shan BE
    Biomed Pharmacother; 2020 Jan; 121():109611. PubMed ID: 31731196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL
    Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marine Actinomycetes-Derived Secondary Metabolites Overcome TRAIL-Resistance via the Intrinsic Pathway through Downregulation of Survivin and XIAP.
    Elmallah MIY; Cogo S; Constantinescu AA; Elifio-Esposito S; Abdelfattah MS; Micheau O
    Cells; 2020 Jul; 9(8):. PubMed ID: 32708048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression.
    Harashima N; Takenaga K; Akimoto M; Harada M
    Oncotarget; 2017 Jun; 8(26):42887-42900. PubMed ID: 28476028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA enhances the effects of TRAIL by downregulating survivin in human ovarian carcinoma cells.
    Lin JY; Ke YM; Lai JS; Ho TF
    Phytomedicine; 2015 Sep; 22(10):929-38. PubMed ID: 26321742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.